These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10212042)
1. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Stegmayr BG; Almroth G; Berlin G; Fehrman I; Kurkus J; Norda R; Olander R; Sterner G; Thysell H; Wikström B; Wirén JE Int J Artif Organs; 1999 Feb; 22(2):81-7. PubMed ID: 10212042 [TBL] [Abstract][Full Text] [Related]
2. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases]. Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritis. Thysell H; Bygren P; Bengtsson U; Lindholm T; Norlin M; Jonsson M; Brun C; Larsen S; Jørgensen F; Sjöholm A; Laurell AB Acta Med Scand; 1982; 212(3):107-14. PubMed ID: 7148502 [TBL] [Abstract][Full Text] [Related]
5. Improved outcome in rapidly progressive glomerulonephritis by plasma exchange treatment. Thysell H; Bygren P; Bengtsson U; Lindholm T; Norlin M; Brun C; Larsen S; Jørgensen F Int J Artif Organs; 1983 Jul; 6 Suppl 1():11-4. PubMed ID: 6642728 [TBL] [Abstract][Full Text] [Related]
6. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346 [TBL] [Abstract][Full Text] [Related]
7. Still a role for plasma exchange in rapidly progressive glomerulonephritis? Levy JB; Pusey CD J Nephrol; 1997; 10(1):7-13. PubMed ID: 9241619 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients. Hu W; Liu Z; Ji D; Xie H; Gong D; Li L J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690 [TBL] [Abstract][Full Text] [Related]
9. Goodpasture's syndrome with absence of circulating anti-glomerular basement membrane antibodies: a case report. Fernandes R; Freitas S; Cunha P; Alves G; Cotter J J Med Case Rep; 2016 Jul; 10():205. PubMed ID: 27459964 [TBL] [Abstract][Full Text] [Related]
11. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy. Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422 [TBL] [Abstract][Full Text] [Related]
12. Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression. Warren SE; Mitas JA; Golbus SM; Swerdlin AR; Cohen IM; Cronin RE Arch Intern Med; 1981 Feb; 141(2):175-80. PubMed ID: 7006545 [TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption in Anti-GBM Glomerulonephritis: Case Report in a Child and Literature Review. Dorval G; Lion M; Guérin S; Krid S; Galmiche-Rolland L; Salomon R; Boyer O Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29054981 [TBL] [Abstract][Full Text] [Related]
14. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. Köhler W; Bucka C; Klingel R J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647 [TBL] [Abstract][Full Text] [Related]
15. Membrane plasma exchange in Goodpasture's syndrome. Keller F; Offermann G; Schultze G; Wagner K; Aulbert E; Scholle J; Faber U; Maiga M; Pommer W Am J Med Sci; 1984; 287(3):32-6. PubMed ID: 6731478 [TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620 [TBL] [Abstract][Full Text] [Related]
17. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis]. Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458 [TBL] [Abstract][Full Text] [Related]
18. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis. Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J Nephron; 1993; 65(2):180-4. PubMed ID: 8247177 [TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Cole E; Cattran D; Magil A; Greenwood C; Churchill D; Sutton D; Clark W; Morrin P; Posen G; Bernstein K Am J Kidney Dis; 1992 Sep; 20(3):261-9. PubMed ID: 1519607 [TBL] [Abstract][Full Text] [Related]
20. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Pusey CD; Lockwood CM; Peters DK Int J Artif Organs; 1983 Jul; 6 Suppl 1():15-8. PubMed ID: 6642729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]